Danaher (DHR)
(Delayed Data from NYSE)
$252.14 USD
+5.91 (2.40%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $252.23 +0.09 (0.04%) 5:16 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Brokerage Reports
Danaher Corporation [DHR]
Reports for Purchase
Showing records 181 - 200 ( 503 total )
Company: Danaher Corporation
Industry: Diversified Operations
Life Science Tools - Vaccine, Bioproduction, mRNA, Cell & Gene Therapy and M&A: 2H21 Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Aldevron Acquisition: Next Move on Bioproduction Chessboard and $9.6B Validation of mRNA and CGT Market Potential for Peers
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Pre-Announced Earnings, but 81% Cytiva Growth
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
''Overnight Success'' with GE and Cepheid M&A: Raising PT from $280 to $315
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department